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Abstract  
Introduction: Migraine, is a common neurological disorder, and its pathology and acute treatment has not 
been determined so far. In the contemporary literature, there is no remedy that can abort an acute episode of 
migraine.  
Objective: We aimed to evaluate the effect of transient presser on the middle part of common carotid artery 
for terminating an acute attack of migraine headache.  
Methods: It is an interventional study without a control limb, performed on patients within age range of 18-
45 years. Patients with established migraine headache based on International Classification of Headache 
Disorders (ICHD) guidelines, who had no atheromatous plaque in their common carotid arteries were 
included. Pain intensity was evaluated by Universal Pain Assessment Tools (UPAT). In safe position, applying 
vital signs monitoring and ipsilateral of headache, a gentle pressure was applied on the common carotid artery, 
lateral to the cricothyroid membrane and medial border of the Sterno-Cleido-Mastoid (SCM) muscle, by using 
both index and middle fingers, till the headache was relieved, following which the pressure was maintained 
for a period of 15 seconds. Then the middle finger was maintained at its position and the index finger slid 
caudally with the same pressure as far a distance of four centimeters and the pressure withdrawn slowly. After 
2 minutes, patients were asked to report any change in headache which was recorded.  
Results: Totally, 215 patients entered this study. The mean of pain score before and after using the technique 
regarding to UPAT, was 6.28±1.34 and 0.4±0.64, respectively; Also, the pain decreases equal 5.88 score was 
significant, special by according sex (p<0.001). No side effect was seen. 
Conclusions: It seems that pressure on the common carotid artery and extending the pressure caudally, 
helped a rapid, safe and significant reduction in pain score for patients with acute attack of migraine headache. 
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INTRODUCTION
Migraine, is a common neurological disorder, and 
its pathology and acute treatment has not been 
determined so far. According to migraine vascular 
theory, cranial arteries dilation in the scalp, dura, 
and pia activates trigeminal pain fibers and trigger 
the subsequent headache. Based on this theory, 
vasoconstrictors such as ergotamine and triptans 
were developed as abortive therapies for migraine. 
But during chemically induced migraine headache, 
vascular changes observed by Imaging studies and 
the controversy over the vascular theory with 
conflicting results has been left unresolved (1). The 
pathogenesis of migraine pain had undergone 
vigorous debate. Patients with migraine frequently 
referred to outpatient clinics, are usually on oral or 
parenteral medication such as triptans for acute 
treatment of episodic attacks. These drugs 
specifically seem to counteract the dilation of some 
arteries and arterioles, including external carotid 
artery branches, and they are classified as 
vasoconstrictors (2-5). Also they are treated with 
botulinum toxoids, acupuncture, traditional 
medicine and other methods (6-8). Newly 
publications refer to a method and apparatus, by 
selectively applying a predetermined electrical 
stimulus of the vagus nerve by implantable devices, 
which can alleviate migraine symptoms, but it is 
not only costly, but invasive as well and the results 
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not decisively fruitful (9, 10). So far, in the 
contemporary literature, there is no remedy that 
can abort an acute episode of migraine. 
Compression of the extracranial arteries in some 
migraine patients during the headache transiently 
decreased the symptoms (11). However, 
amelioration of pain with this procedure only 
occurs during the period of compression itself, but 
in this study, we evaluated a new technique by 
compression effect on common carotid artery in 
reliving migraine attack headache, to become 
considerably less in intensity.  
Methods 
Study design and setting  
This was a single-arm interventional study 
performed from September 2019 until March 2020 
in Tehran, Iran. Written informed consent from the 
patients and approval form the ethical committee 
of Tehran University of Medical Sciences were 
obtained (code: IR.TUMS.IKHC.REC.1397.182). The 
authors accepted Declaration of Helsinki 
principles. The protocol of the study has been 
registered in www.irct.ir and a specific code has 
been assign to it (Registry code: 
IRCT20150116020676N4). 
Participants and Intervention 
The patients were evaluated by consensus 
sampling. Patients aged 18-45 years who had an 
established migraine headache and referred to our 
clinic through an advertisement announced by our 
pain outpatient departments were recruited 
patients with established migraine based on 
International Classification of Headache Disorders 
(ICHD) guidelines (12), in whom color doppler 
sonography of the common carotid arteries 
depicted no narrowing of the common carotid 
arteries or any atheromatous plaque were 
included. Patients with histories of syncopal 
attacks, sensitivity of carotid sinus, cardiac 
dysrhythmia, history of any neurologic disease, 
patients with another non migraine headache 
symptoms and basilar migraine were excluded. 
The patients continued their medications as 
prescribed by their physicians. All patients had 
Doppler echo of the carotid arteries to rule out any 
narrowing of the carotid arteries or any 
atheromatous plaque in the arteries. The pain score 
at the time of admission was not considered owing 
to the fact that the intervention was extremely 
short, in the event of failure in the reduction of pain 
or else an increase in the intensity of pain, the 
intervention was aborted and patient allowed to 
take his medications as before. After having 
obtained an informed consent, and having 
evaluated the pain intensity according to the 
Universal Pain Assessment Tools (UPAT), the 
patient was seated on a chair and conventional 
monitors (pulse oximetry, non-invasive blood 
pressure, electrocardiography) applied, and 
resuscitative trolley made available. Then 
depending on the site of the headache, the 
landmark was identified by palpating the 
cricothyroid membrane by the finger of person 
performing the intervention (Figure 1). Then the 
finger was slid laterally till it reached the medial 
border of the Sterno- Cleido –Mastoid muscle 
(SCM), a point coinciding with the carotid sinus 
(13). Then using both index and middle fingers, a 
gentle pressure was applied on the middle part of 
the common carotid artery. After having applied 
the pressure, the patient was asked whether the 
pulsatile headache got terminated or not. If the 
 
Figure 1: Pressure applied on the anterior border of SCM, 
at the crico-thyroid cartilage level. 
 
 
Figure 2: Index finger slid 4 centimeters caudally while the 
middle finger maintaining the same pressure as before. 
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patient`s headache was not relieved, the index and 
the middle fingers, were moved so as to impinge 
the common carotid artery between them and the 
pressure applied again. If the headache had been 
terminated, the tactile finger pressure was 
maintained for a period of 15 seconds. Then the 
middle finger was maintained at its position and 
the index finger slid caudally with the same 
pressure as far a distance of four centimeters 
(Figure 2) and pressure withdrawn slowly. After a 
lapse of 2 minutes, the patient was asked to report 
any change in headache which was recorded. Then 
the patient was asked to lie down in a bed and vital 
signs monitored for a period of 1-hour following 
which the patient was discharged. 
Data analysis 
All the data were analyzed using SPSS VER 18. 
Frequency and percentage are used for 
demonstrating qualitative data and mean and SD 
for quantitative data. Paired sample T test was used 
for evaluation of pain mean difference before and 
after intervention. A P-value less than 0.05 was 
considered as significant. 
RESULTS 
Totally, 215 patients entered this study. 
Demographic factors and clinical signs of patients 
with migraine headache history by sex are being 
depicted in (Table 1).  The mean age of patients was 
32.3±6.3 and 155 patients (72.1%) were female 
and 60 patients (27.9%) were male. Of all 
participants, 94.9% of patients had photophobia 
,87.0% had nausea, and 82.8%, had phonophobia. 
All of the patients had one of the clinical signs (such 
as nausea, vomiting, photophobia, phonophobia 
and aura) and 56.7% had three positive signs 
simultaneously (Figure 3). The distribution of 
clinical signs did not have any significant difference 
 
Figure 3: The veen diagram of clinical signs` frequency (%) of migraine patients 
 
Table 1: Demographic factors and clinical signs of patients with migraine headache history by sex 
Variable Total patients (n=215) 
Sex 
P-value 
Male (n=60) Female (n=155) 
Age (mean±SD), year 32.3±6.3 31.9±5.9 32.4±6.5 0.563 
Duration of Migraine (mean±SD), year 11.9±4.7 11.9±4.9 11.8±4.6 0.895 
Aura, (%)    79 (36.7) 23 (38.3) 56 (36.1) 0.764 
Photophobia, (%)  204 (94.9) 57 (95.0) 147 (94.8) 1.0 
Phono phobia, (%)     178 (82.8) 48 (80.0) 130 (83.9) 0.500 
Nausea, (%)  187 (87.0) 53 (88.3) 134 (86.5) 0.713 
Vomiting, (%) 186 (86.5) 9 (15.0) 20 (12.9) 0.686 
Triptan, (%) 26 (12.1) 8 (13.3) 18 (11.6) 0.729 
Boutax, (%)    13 (6.0) 5 (8.3) 8 (5.2) 0.359 
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according to gender distribution(p>0.05). All 
patients received nonsteroidal anti-inflammatory 
drugs (NSAIDs) treatment, 12.1% had history of 
receiving triptans and 13 patients (6.0%) had 
received Boutax injections. The mean of migraine 
history was 11.9±4.7 year which was not statically 
significant among patients of both sexes (p=0.895). 
The pain score before intervention was ≥3 
according to UPAT score, and more than 85% of 
patients had scores between 5 to 8. Pain score after 
treatment in more than 90% of patients was ≤ 
3(between 0-10) (Figure 4). Pain score mean 
before treatment was 6.28±1.34 and 0.4±0.64 at 
and after the technique, respectively. The mean of 
pain decreased to a score of almost 5.88 (p<0.001) 
(Table 2) which was statically significant. This, 
decrease was significant according sex (p<0.001) 
(Table 2). The general linear model (GLM) analysis 
showed that age (p=0.712), duration of migraine 
(p=0.162) and sex (p=0.155), did not have effects 
covariate on outcome. There was also no significant 
relation reported between pain difference score 
with age (r=-08, p=0.267), and duration of 
migraine (r=-0.09, p=0.181).  
DISCUSSION 
In our study, we evaluated 215 patients who were 
being treated for migraine headache and fulfilled 
the ICDH criteria for migraine headache. The 
results of this maneuver showed a significant 
reduction in the UPAT pain score of migraine 
headache in less than one minute.  
 
Figure 4: Distribution of pain score before and after intervention 
 
Table 2: Mean pain score before and after intervention, and mean difference by sex 
Sex 
Mean of pain score (±SD) 
P-value Mean difference (±SD) 
Before intervention After intervention 
Male (n=60)  6.43±1.45 0.50±0.73 <0.001 -5.93±1.44 
Female (n=155) 6.22±1.29 0.36±73 <0.001 -5.86±1.34 
P-value 0.294 0.191  0.717 
Total (n=215) 6.28±1.34 0.40±0.64 <0.001 -5.88±1.36 
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Headache is considered as a major health issue 
with a prevalence of active headache disorders in 
the general population and also in both sexes, its 
prevalence peaks between 25 to 55 years of age 
and has significant direct and indirect costs and in 
the workplace, it can be increased in burnout due 
to active headaches disorders (14-17). Many 
medications and methods have been advocated, 
but as the pathogenesis of migraine is not clear and 
debatable, treatment options remain uncertain. 
Other studies have shown, that prior to the onset of 
headache, vasoconstriction and increased 
resistance to blood flow occurs. They concluded 
that the extra cranial arteries are a major source of 
pain in migraine (18, 19). These studies also 
observed tenderness of the dilated arteries, which 
suggested that some migraine pain may emanate 
from the arterial walls (20, 21). Some studies 
provided a rationale for the use of drugs that 
relieve migraine pain by reversing vasodilation in 
the extra cranial vascular system, in particular, 
ergotamine tartrate (22-24). Management of acute 
migraine by pharmacological approach has not 
changed much since 2012. The mainstays of acute 
migraine therapy presently are non-steroidal anti-
inflammatory drugs (NSAIDs), triptans, 
antiemetics, and etc. (25, 26). Different type of non-
oral and oral preparations of triptans and NSAIDs 
such as (nasal sprays, intravenous/intramuscular 
injection, transdermal patches, and oral powder 
formulations), might improve the action efficacy, 
by more rapid onset than that of existing 
medications (27). Acute treatment response is 
most effective when these medications are 
administered, within 15 minutes of the onset of 
pain (28). Since these drugs take a few minutes to 
show their effect, which indeed might be a long 
period for patients with headache. Also these drugs 
have side effects such as nausea, vomiting, 
tachycardia and palpitation, uncontrolled 
hypertension, hemiplegic migraine and vascular 
disease (29-35). Other studies revealed that the 
role of the extra cranial terminal branches of the 
external carotid artery, provided convincing 
evidence of their involvement in the progression of 
migraine pain and it led to the propose that the pain 
of migraine originated in the distended extra 
cerebral arteries (32). These studies showed that 
the change in pulsations of branches of the external 
carotid arteries (occipital and superficial temporal) 
had a direct relation with the intensity of migraine.  
Factors such as ergotamine tartrate can decrease 
the amplitude of pulsations and intensity of 
headache and with this effect amplitude of 
pulsations of the temporal and occipital arteries 
decreased to almost 50%. When the amplitude of 
pulsations rapidly decreased, dimension of pain 
intensity rapidly changed, too and this effect, was 
seen as vice versa. In a study, compression of 
extracranial artery during migraine headache 
reduced or eliminated the pain. Some researches 
had noted that the terminal branches of carotid 
artery, might be a source of migraine pain (11). 
Another technique by vagus nerve stimulation 
(VNS) was successful in regarding the pain (36). In 
another study at first treated attack, VNS could 
affect pain in four out of 19 (21%) (37). Similar 
reduction of pain using VNS. was reported in 
another study (38). A pressure on the carotid 
artery for the relief of headache has been of some 
help, but its etiology is somehow not understood. 
Some hypothesis exists for such a relief:  
 Hypothalamus, an important autonomic center 
in the brain could be involved in migraine 
headache as the symptoms of the headache tally 
with the alteration in autonomic nervous system.       
Activation of neurons in the locus coeruleus (LC) 
is believed to mediate many of the effects of 
vagus nerve stimulation (VNS) in the central 
nervous system (CNS). LC is the largest 
noradrenergic nucleus in the brain; Despite LC, 
some other neural activity was seen due to VNS 
(39). Structures related to both sympathetic and 
parasympathetic processing, such as the LC, also 
exhibited better hypothalamic connectivity.  The 
LC could be involved in both normal and 
abnormal pain modulation during migraine 
because of its supposed involvement in the 
inhibition of nociceptive reflexes and the firing 
mode of thalamic and prefrontal neurons in 
response to noxious stimuli raise the possibility 
that during migraine some involvements in 
normal or abnormal pain modulation may 
happen. Factors that have been mentioned in 
favor of this maneuver could be an excitatory or 
inhibitory effect on the messages which have an 
effect on the neuronal discharge over the LC, 
which has been mentioned as a cause of migraine 
(40, 41). 
 Some studies have mentioned dilation of the 
extra cranial vessels as a cause of migraine. A 
pressure on the carotid artery causes a reduction 
of flow in these arteries and thus terminates the 
episode of migraine. But it is not known as to why 
the symptoms do not return after withdrawal of 
the pressure. 
 Moreover, the presence of the stellate ganglion 
and its role in sympathic mediated pain has not 
been fully elucidated. 
 The internal and external jugular vessels lying in 
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the vicinity could also be playing some role in the 
genesis of migraine headache. 
Our maneuver, the tactile pressure, could be of 
value in patients who do not use any medications 
or else pregnant patients who pose some 
limitations in taking drugs. Likewise, it could also 
be helpful for pilots, drivers or people who do 
exhaustive works and had to remain fully alert 
during skillful assignments. This technique can be 
easily accomplished by the patient himself or 
his/her companion.  
Limitations 
A possible limitation of this study was that a control 
group was not included. Having debated over this 
issue, it was decided that a control loop could not 
be included because it was literally impossible as 
no intervention as a control group could have given 
us instantaneous reward as is evident in our 
intervention group thus defeating the very purpose 
of including a control group.  
CONCLUSIONS 
Direct Tactile pressure on the common carotid 
artery and extending the pressure caudally helped 
in relieving the migraine headache but we can only 
make a cautious conclusion in this regard as a 
control loop was lacking. 
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